About The Journal
Advancing Healthcare Through Research: About International Journal of Medicine And Clinical Trials (IJMC) by Sciforce Publications
Enter the world of medical research, clinical trials, and scientific exploration with the International Journal of Medicine And Clinical Trials (IJMC), a prestigious publication by Sciforce Publications. IJMC serves as a beacon for the latest research, innovations, and advancements in the field of medicine and clinical trials, offering insights into medical treatments, patient care, and the dynamic world of healthcare research. In this "About Us" section, we will provide an overview of IJMC, its mission, and its commitment to advancing knowledge in medicine and clinical research.
IJMC - International Journal of Medicine And Clinical Trials:
- A Gateway to Medical Knowledge: Sciforce Publications is renowned for its commitment to scientific rigor and innovation, and IJMC embodies this commitment. The journal is dedicated to providing a platform for disseminating groundbreaking research in the fields of medicine and clinical trials.
- Comprehensive Focus: IJMC covers a wide spectrum of topics within medicine and clinical research, including disease management, treatment strategies, clinical trial design, healthcare innovations, and more. It serves as a comprehensive resource for researchers, healthcare professionals, clinicians, and individuals interested in the evolving landscape of medical science.
- Peer-Reviewed Excellence: Every article published in IJMC undergoes a meticulous peer-review process, ensuring the highest standards of quality and scientific integrity. IJMC stands as a trusted source of knowledge for researchers, healthcare practitioners, and medical enthusiasts.
Our Mission:
At IJMC, our mission is to advance understanding and knowledge in the dynamic fields of medicine and clinical trials. We aim to:
Facilitate Medical Research: Provide a platform for researchers and healthcare professionals to publish their findings, innovations, and discoveries related to medical treatments and clinical research.
Promote Evidence-Based Medicine: Foster the use of evidence-based practices in healthcare by disseminating research that informs clinical decision-making and patient care.
Support Collaboration: Encourage collaboration among experts in medical research, clinical trials, and healthcare delivery to improve patient outcomes and advance medical science.
Contributions to Scientific Advancement:
- Medical Research: IJMC showcases pioneering research in various medical specialties, offering insights into disease mechanisms, treatment modalities, and patient care strategies.
- Clinical Trial Design: The journal often features studies that address innovative clinical trial designs, patient recruitment strategies, and methodologies that improve the efficiency and ethical conduct of trials.
- Healthcare Innovation: IJMC explores healthcare innovations, from the development of medical devices to the implementation of digital health solutions that enhance patient monitoring and care delivery.
Impact on Healthcare:
The research published in the International Journal of Medicine And Clinical Trials has profound implications for healthcare and patient outcomes:
- Patient-Centered Care: IJMC plays a pivotal role in advancing patient-centered care by disseminating research that informs clinical practice and treatment decisions.
- Medical Advancements: Insights from IJMC contribute to medical advancements, influencing the development of new therapies, interventions, and healthcare technologies.
- Ethical Clinical Research: IJMC fosters scientific progress by promoting ethical conduct in clinical research, ensuring the safety and well-being of research participants and patients.
Aim and Scope
Clinical trials are observations in clinical research which describes the safety and efficacy of medications, diagnostic products and treatment regimens which mainly developed for human use. These trials are also used for diagnosis, treatment, prevention, relieving the symptoms of a disease. In the pharmaceutical field clinical trials give main preference to newly invented drugs/medicines. These clinical trials include four phases which accurately gives the result of newly invented drug. Dose of the drug, half life of the drug and its various actions at various stages can be known more accurately. Phases zero, 1, 2, and 3 are the four phases of clinical trials which ultimately describes the pharmacodynamics, screening for safety, Establishing the efficacy of the drug, and Final confirmation of safety and efficacy, Safety studies during sales respectively.
Sciforce International Journal of Medicine And Clinical Trials (IJMC) journals and research papers are a gateway to the community of Medicine And Clinical Trials experts, researchers and peers. While adhering to the international standards of online publishing, IJMC aims to publish high quality, informative, scientific and well-researched content.
International Journal of Medicine And Clinical Trials
- Adverse Drug Events Reporting
- Clinical Trials
- Common Cancers
- COPD
- Depression
- Electronic Health Records
- Gastroesophageal reflux
- Genomic Medicine
- Geriatrics
- Health Diversity
- Healthcare Reform & the ACA
- Hospital Medicine
- Hypertension
- Immunization
- Lipids and Cardiovascular Risk Management
- Menopause
- Microbiome
- Migraine
- Moderate to Severe Asthma
- Obesity and Weight Management
- Pain Management
- Palliative Care
- Patient Safety
- Rare Diseases
- Residents
- Skin Rash
- Somatic Disorders
- Substance Abuse
- Substance Abuse and Addiction
- Wireless Medicine
The International Journal of Medicine And Clinical Trials by Sciforce Publications is dedicated to advancing knowledge in medicine, clinical research, and healthcare innovations. Its commitment to scientific excellence, innovation, and impactful research makes it an invaluable resource for researchers, healthcare professionals, clinicians, policymakers, and anyone passionate about improving healthcare outcomes and advancing medical science. Explore the pages of IJMC to stay updated on the latest developments and breakthroughs in medicine and clinical research, and join us in our mission to advance healthcare through rigorous scientific inquiry and evidence-based practice.